Characteristics | All patients 23 (100%)a | NR 7 (30%) | PR 10 (43%) | TR 6 (26%) | p valueb |
---|---|---|---|---|---|
Tumor diff. after treatment | 0.064 | ||||
No surgery | 3 (13) | 0 | 0 | 3 (50) | |
Missing value | 5 (22) | 2 (29) | 1 (10) | 2 (33) | |
Well | 5 (22) | 1 (14) | 4 (40) | 0 | |
Moderately | 9 (39) | 3 (43) | 5 (50) | 1 (17) | |
Undifferentiated | 1 (4) | 1 (14) | 0 | 0 | |
Post-treatment stage | 3.3e−08 | ||||
0 | 6 (26) | 0 | 0 | 6 (100) | |
I | 7 (30) | 0 | 7 (70) | 0 | |
IIA | 3 (13) | 2 (29) | 1 (10) | 0 | |
IIIA | 2 (9) | 0 | 2 (20) | 0 | |
IIIB | 2 (9) | 2 (29) | 0 | 0 | |
IIIB–IIIC | 3 (13) | 3 (43) | 0 | 0 | |
ypT | 4.6e−08 | ||||
T0 | 6 (26) | 0 | 0 | 6 (100) | |
T1 | 3 (13) | 0 | 3 (30) | 0 | |
T2 | 6 (26) | 0 | 6 (60) | 0 | |
T3 | 7 (30) | 6 (86) | 1 (10) | 0 | |
T4 | 1 (4) | 1 (14) | 0 | 0 | |
PNI | 1 | ||||
+ | 2 (9) | 1 (14) | 1 (10) | 0 | |
− | 21 (91) | 6 (86) | 9 (90) | 6 (100) | |
LVI | 0.002 | ||||
+ | 8 (35) | 6 (86) | 2 (20) | 0 | |
− | 15 (65) | 1 (14) | 8 (80) | 6 (100) |